Frontlight ResearchEarly access
CompletedNo phase
Assessment of the Role of Probiotics in Prevention of Ventilator-Associated Pneumonia in Neonates
Key facts
- Who runs it
- Lamiaa Khaled Zidan
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 1 May 2023
- Ended
- 1 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Probiotic
- Record updated
- 3 June 2025
Who can take part
- Age
- 1 day to 28 days
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- All term neonates who required mechanical ventilation with ETT for more than 48 hours
Who cannot take part
- Surgical causes of mechanical ventilation
- Early-onset neonatal sepsis
- Pre-existing pneumonia
- A patient who was unfit for enteral intake
- Prematurity <37 gestational weeks
- Multiple congenital anomalies and suspected chromosomal anomalies
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Evaluate the preventive value of probiotics on VAP among ventilated neonates.
The 2 groups in the trial
- Probiotic groupExisting treatment, for comparison
40 ventilated neonates who received commercially available probiotics
Treatment: Probiotic
- Non-probiotic groupNo study treatment, for comparison
40 ventilated neonates who only received the standard of care treatment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Assessment of the role of probiotics in prevention of ventilator-associated pneumonia in neonates.European journal of pediatrics, 2025
- Record updated
- 3 June 2025